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Background: In dorsal spinal neurons and monocytes, bone morphogenetic protein (BMP)7 activates distinct
transduction pathways, one leading to inductive specification and the other to axon orientation and chemotaxis.
BMP7-evoked induction, also stimulated by the closely related BMP6, acts through a Smad cascade, leading to
nuclear signaling, and is not BMPR subunit selective. Orientation is evoked by BMP7, but not by BMP6, through
PI3K-dependent cytoskeletal activation mediated by the type II BMPRs, ActRIIA and BMPRII and is independent of
the Smad cascade. The responses can be stimulated concurrently and suggest that BMP7, but not BMP6, can
selectively activate BMPR subunits that engage the divergent paths. Although structural and biochemical analyses of
selected BMP/BMPR interfaces have identified key regions of interaction, how these translate into function by
related BMPs is poorly understood. To determine the mechanisms underlying the distinct activities of BMP7 and the
disparate properties of BMP7 and BMP6 in spinal cord development, we have performed a family-wide structure/
function analysis of BMPs and used the information to predict and test sites within BMPs that may control agonist
properties, in particular the ability of a BMP to orient axons, through interactions with BMPRs.
Results: We demonstrate that whereas all BMPs can induce dorsal neurons, there is selectivity in the ability also to
orient axons or evoke growth cone collapse. The degree to which a BMP orients is not predictable by overall
protein similarity with other BMPs but comparison of sequences of potent and weakly orienting BMPs with that of
the non-orienting BMP6 revealed three candidate positions within the BMPs at which the amino acid residues may
confer or obstruct orienting ability. Residue swapping analysis has identified one residue, Gln48 in BMP6, that blocks
axon orienting ability. Replacing Gln48 with any of the amino acids present at the equivalent residue position in the
orienting subset of BMPs confers orienting activity on BMP6. Conversely, swapping Gln48 into BMP7 reduces
orienting ability. The inductive capacity of the BMPs was unchanged by these residue swaps.
Conclusions: The results suggest that the presence of the Gln48 residue in BMP6 is structurally inhibitory for BMP/
BMPR interactions that result in the activation of intracellular signaling, leading to axon orientation. Moreover, since
residue 48 in BMP7 and the corresponding residue in BMP2 are important for type II BMPR binding, our results
provide a basis for a mechanistic understanding of the diverse activities of BMPs in spinal cord development.Background
Bone morphogenetic proteins (BMPs) represent a class of
TFGβ factors with diverse functions in mammals. BMPs
evoke transcriptional events leading to cellular differenti-
ation and survival [1,2] but also direct axon guidance and
cellular orienting activities through cytoskeletal signaling
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a range of extracellular and intracellular modulators of
BMP/BMPR interactions [6,7] suggest that differential ex-
pression of these BMP signaling components could pro-
duce the many actions of BMPs. However, in neurons and
monocytes, a single BMP can simultaneously evoke both
transcriptional and cytoskeletal responses that involve dif-
ferent receptor subunits and divergent intracellular signal-
ing programs [3,8,9], suggesting additional mechanisms
that supersede the simple distribution of transduction
components. Moreover, the ability to activate divergent
pathways is not necessarily shared by closely related BMPs,ntral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Perron and Dodd Neural Development 2012, 7:16 Page 2 of 14
http://www.neuraldevelopment.com/content/7/1/16highlighting the importance of individual agonist proper-
ties [8,9]. We sought here to understand the properties
that underlie the selective ability of a BMP to exert diver-
gent orienting activity.
In the mammalian central nervous system (CNS),
BMP6, BMP7 and the more distantly related GDF7, are
expressed with overlapping distribution in the roof plate,
at the dorsal midline of the developing spinal cord [4,10].
Roof plate BMP activity mediates the induction of dorsal
spinal interneurons (dI neurons) [10,11] and the subse-
quent guidance of the axons of nascent dI neurons but
examination of the individual BMPs uncovered different
roles for these family members during spinal cord develop-
ment [4,12]. Comparison of the inductive and orienting ac-
tivities of BMP6, BMP7 and GDF7 in spinal explants
revealed that while all three induce ectopic dI neurons,
only BMP7 can also orient extending dI axons [4,10,12].
Moreover, whereas BMP6 stimulates induction but has no
orienting activity in dissociated dI neurons or monocytes,
BMP7 activates inductive signaling and also evokes growth
cone collapse in dI neurons and chemotaxis in monocytes
[4,9,12]. Nonetheless, the different activities of the closely
related BMP6 and BMP7 in dorsal spinal development
have remained a puzzle.
The results summarized above, combined with the find-
ing that orienting responses to BMP7 are initiated at much
lower concentrations than BMP-evoked inductive signal-
ing in the same cells [3,8,9], led to the idea that, whereas
both BMP7 and BMP6 engage receptor complexes that ac-
tivate intracellular inductive machinery, BMP7 alone
recruits a distinct receptor complex that directs signaling
towards the cytoskeleton. In support of this, we and others
have provided evidence that the type II BMPR subunits,
ActRIIA and BMPRII, and the type I BMPR subunit,
BMPRIB, are required selectively by BMP7 to activate cel-
lular orienting responses of neurons and monocytes but
are not individually essential for BMP inductive activity
[8,13]. In recent work, both BMP7 and BMP6 have been
shown to activate Smad signaling and dI neuron induction
through the activity of type I BMPR kinases, whereas
BMP7-evoked axonal orientation is independent of type I
BMPR kinase activity [9]. Furthermore, BMP7, but not
BMP6, activates a PI3K-dependent pathway required for
axon orientation but PI3K-dependent signaling is not
required for BMP7-stimulated induction [9]. Together,
these findings suggest a model whereby the ability of
BMP7 to stimulate divergent intracellular pathways within
a cell results from the differential recruitment and/or acti-
vation of BMPRs, but a mechanistic explanation for such
selective subunit recruitment is still lacking.
BMPs bind as dimers to BMPR complexes comprising
one pair each of type I BMPR and type II BMPR subunits
[6]. Classically, phosphorylation of the type I receptors by
the type II receptor pair leads to stimulation of theintracellular cascade of activated Smads [1,14] resulting in
transcriptional signaling. In addition, however, type II
BMPRs appear to interact directly with signaling inter-
mediates that regulate cytoskeletal events [15,16]. Vari-
ation in receptor composition and the mode of receptor
subunit recruitment by different BMPs are thought to con-
tribute to choice of distinct intracellular pathways [17,18]
and this notion, combined with differences in binding po-
tencies of BMPs to BMPRs [19-21], suggests that individ-
ual BMPs may achieve distinct cellular outcomes through
differential usage of subunits in BMPR complexes.
An unresolved issue, however, is the basis for selective
agonist interactions with these BMPR subunits. Struc-
tural modeling and binding studies of BMP interactions
with the extracellular domains (ECD) of BMPRs have
identified sites of interaction between select BMPs and
type I and type II BMPRs [22-24]. Indeed, the predicted
BMP7/ActRIIA and BMP2/BMPRIA interfaces are
known and found in spatially distinct regions [23,25,26].
It seems likely that understanding how these regions of
the BMPs contribute to their agonist properties will elu-
cidate the mechanisms underlying selective BMP func-
tion in developing spinal cord. We have, therefore,
performed a structure/function analysis across the BMP
family, examining inductive, growth cone collapsing and
axon orienting ability on dI neurons. We have used this
information to identify features of the primary structure
of BMPs that may control orienting ability and have
begun to test these inferences using a residue swapping
approach. Our analysis reveals one residue within the
putative type II BMPR binding domain of BMP7 and
BMP6 which is critical for orienting ability, while not im-
pinging on inductive capacity. These results suggest a
model for the mechanism underlying the ability of BMPs
to recruit or activate selectively certain BMPR subunits
leading to axon orientation signaling.
Results
Characterization of orienting activity across the BMP
family
In addition to orienting dI axons, BMP7 has a direct and
rapid effect on dissociated dI neurons, evoking growth
cone collapse within minutes and providing a convenient
and direct bioassay for orientation ability [4,9]. To illus-
trate the disparate actions of the roof plate-resident
BMPs, we tested recombinant (r) BMP7, rBMP6 and
rGDF7, at the same concentrations, in parallel growth
cone collapse and induction assays. We used 50 ng/ml
rBMPs, a concentration well above threshold for both
the inducing activity of BMP6 or BMP7 (approximately 5
ng/ml) and the growth cone collapse activity of BMP7
(0.01 ng/ml; [9]). Explants of intermediate neural tube
([i] explants) were incubated in BMP then probed for the
differentiation of dI1 neurons, marked by expression of
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as previously described [9]. All three BMPs induced
Lhx2/9 expression (Figure 1A), indicating that they were
functional at this concentration. However, only rBMP7
reduced the area of growth cones (30% reduction;
Figure 1B, C) whereas rBMP6 and rGDF7 had no effect
on growth cone size (Figure 1B, C). The results are con-
sistent with findings in which BMP7, but not BMP6 or
GDF7, orients dI axons in explants of embryonic dorsal
spinal cord ([d] explants) [4,9,12] and support the notion
that the inability to orient axons by BMP6 and GDF7
reflects different agonist properties rather than concen-
tration issues.
The disparate activity profiles of the roof plate BMPs
prompted us to perform a comprehensive analysis of the
dI axon orienting and dI inductive abilities across the
BMP family. The activities of BMPs and several other
members of the transforming growth factor (TGF)β
superfamily were tested in [d] explants. In this prepar-
ation, COS-1 cell aggregates expressing epitope-tagged
proteins are appended asymmetrically to the explants.
The effects of expressed BMPs on orientation of TAG-1+
axons of endogenous dI neurons and induction of ec-
topic Lhx2/9+ dI1 neurons in [d] explants are examined
concurrently [4,9,12]. We first assessed the production of
BMPs and TGFβs by measuring the secretion of epitope-Figure 1 Differential activity of roof plate-resident BMPs in induction
explants exposed to 50 ng/ml rBMP7, rBMP6 and rGDF7. Scale = 25 μm. (B)
ng/ml. Arrowheads indicate typical widespread growth cones and asterisks
shown in the left column (scale = 40 μm) and high power confocal images
cone areas (mean± SEM): Control = 114.3 ± 10.7 μm2; BMP7= 79.5 ± 7.4 μm2
growth cone area measured in BMP7 is significantly different from control,
or GDF7 did not differ from control (P = 0.0607 and P= 0.2105, respectivelytagged proteins into medium conditioned by transfected
COS-1 cells. Each conditioned medium (CM) was exam-
ined by Western blot, using BMP-specific antibodies or
antibodies that recognize the epitope tag (HA, myc or
flag). Concentrations of BMPs were estimated by com-
parison with Western blot standard curves for given
rBMPs, shown here for BMP9 (Figure 2A). CM collected
from COS-1 cells expressing myc- (Figure 2B) or HA-
tagged (Figure 2C) BMPs contained similar levels of
secreted protein independent of the epitope tag used, in
the range of 250 to 500 pg/ml. Moreover, in this study
the concentrations of all BMPs and TGFβs in CM were
similar (not shown).
We next appended pellets of BMP- and TGFβ-expressing
COS-1 cells to [d] explants and measured the orientation
of TAG-1+ dI axons growing within the explants. In [d]
explants cultured adjacent to control COS-1 cells expres-
sing empty vector, pMT23, dI axons extended with a dorsal
to ventral (D-V) trajectory (angle of orientation
(pMT23): -3.5 ± 1.6°; Figure 3A and 3C (green bars)). In
[d] explants with appended BMP7-expressing COS-1
cells, TAG-1+ axons were repelled, extending away from
the BMP7 source, with an angle of orientation of
35 ± 1.9° (Figure 3A, C). Three other BMPs, BMP9, BMP4
and BMP2, also showed robust orienting activity with a
range of orientation angles of 27 to 38° (Figure 3A, C;and dI neuron growth cone collapse. (A) Lhx2/9 induction in [i]
ERM-labeled dissociated dI neurons ± rBMP7, rBMP6 or rGDF7 at 50
indicate collapsed growth cones. Low power fluorescence images are
are shown in the right column (scale = 10 μm). (C) Average growth
; BMP6= 127.4 ± 11.9 μm2; GDF7= 122.4 ± 11.7 μm2. Student’s t tests:
BMP6 and GDF7 (***P<0.001); growth cone area in response to BMP6
). Results are for 100 to 115 growth cones/condition/experiment; n = 2.
Figure 2 Generation of BMP conditioned medium (CM). (A-C)
Western blots of rBMPs and 20-fold concentrated CM. (A) rBMP9 at
the indicated concentrations and BMP9 CM probed with α-BMP9. (B)
myc-tagged BMP CM probed with α-myc. (C) HA-tagged BMP CM
probed with α-HA. In CM lanes, the lower bands represent BMP
monomers migrating at 18 kDa for BMP7 and BMP6, 15 kDa for
GDF7 and 13 kDa for BMP9. The upper bands represent glycosylated
forms of the BMPs.
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BMP5 and dorsalin-1 showed intermediate orienting activ-
ities with a range of orientation angles of 12 to 19°
(Figure 3C; GFD6: 19 ± 2.1°; BMP5: 16± 1.8°; dorsalin-1:
12 ± 2.8°), whereas BMP6, GDF5 and GDF7 showed little
or no activity which was statistically not different from
control (Figure 3A, C; range of orientation angle: 4 to 7o;
BMP6: 7 ± 2.2°; GDF5: 7 ± 2.2°; GDF7: 4 ± 1.5°). The non-
BMP, TGFβ family members, TGFβ3, TGFβ2, GDF15 and
Activin A, were all inactive in axon orientation (Figure 3C
and not shown; Range of orientation angle: -6 to 0.6o;
TGFβ2: 0.6± 2.8°; TGFβ3: -2± 1.6°; GDF15: -3± 3.9°; Acti-
vin A: -6± 1.2°).
The ability of the BMPs and TGFβs to induce differen-
tiation of ectopic dI neurons was assessed by measuring
ectopic Lhx2/9 expression (Figure 3B) in the same set of
[d] explants used to record axon orientation. In control
[d] explants, cultured adjacent to pellets of COS-1 cells
expressing pMT23, endogenous expression of Lhx2/9
was restricted to dorsal regions of the explants (Figure 3B
and see [9]). In [d] explants co-cultured with BMP7-
expressing COS-1 cells ectopic Lhx2/9 expression was
observed (Figure 3B). The D-V extent of Lhx2/9expression was expanded in response to BMP7, reflecting
a 2.7-fold increase in dI1 neurons (Figure 3C (red bars)).
All 10 BMPs showed similarly robust dI1-inducing ability
(Figure 3B, C) stimulating induction of Lhx2/9+ cells in a
range of 153 to 215% over control. None of the other
TGFβs tested induced ectopic Lhx2/9 expression
(Figure 3C). These results indicate that although all
BMPs have dI1 neuron inducing capacity, only a subset
exhibits axon orienting activity.
Discrete structural distinctions correlate with the ability of
BMPs to orient axons
BMPs fall into closely related subgroups assigned accord-
ing to overall mature protein similarity (see Figure 3D).
Comparison of subgroup relationships with respect to
orienting activity of BMPs (compare Figure 3C and D)
revealed that axon orienting BMPs are not those most
highly related by overall amino acid similarities. BMP7,
BMP6 and BMP5 represent the most closely interrelated
subset of BMPs (Figure 3D) yet display orienting activity
that can be categorized as high, insignificant and inter-
mediate, respectively (Figure 3C (green bars)). BMP9 is
relatively distantly related to BMP7 yet has the most
comparable orienting ability. The capacity to induce
ectopic Lhx2/9 expression was similar across the family of
BMPs but did not extend to other members of the TGFβ
family (Figure 3C (red bars)). Thus the ability of BMPs to
induce neural character appears to be a property common
to all BMPs, but the ability of BMPs to orient is restricted
to a subset of active BMPs that does not mirror groupings
according to overall structural similarity.
To look in more detail for primary structural compo-
nents that might affect the ability of BMPs selectively to
activate downstream signaling leading to orientation, we
aligned the amino acid sequences of the mature, secreted
protein regions of BMP6 and BMP7 (Figure 4A), choos-
ing to compare these initially because they are the most
closely similar BMPs that show the maximum divergence
functionally. Allowing for conservative amino acid sub-
stitutions in the sequences, BMP6 and BMP7 could be
seen to have 95% similarity, with non-conservative amino
acid differences at only eight positions, dispersed across
the sequence (Figure 4A). Notably, BMP5, the other
member of this structural subgroup and displaying inter-
mediate orienting activity, was found to be 97% similar
to BMP7 and shares with BMP7 four of the residues that
are divergent in BMP6. Three of these are grouped at
the N-terminal region, at positions 36, 48 and 60. But
BMP5 also shares with BMP6 two of the residues,
located closer to the C-terminal end of the protein, that
diverge from the BMP7 sequence, at positions 93 and
108 (Figure 4A). These observations raised the possibility
that residues that are shared by BMP7 and BMP5, but
absent in BMP6, promote orienting activity, and/or
Figure 3 A subset of BMPs, not predictable by structure, has orienting ability. (A, B) [d] explants with asymmetrically appended COS-1 cell
aggregates expressing myc-tagged BMPs co-labeled with α-TAG-1 (green), α-Lhx2/9 (red) and α-myc (blue). Dashed lines mark appended borders
of explants and aggregates. (A) dI axon responses in [d] explants. Arrowheads indicate axons repelled by BMPs. Scale = 50 μm. (B) BMP-stimulated
induction of ectopic Lhx2/9 expression in [d] explants. Double-headed arrows mark width of Lhx2/9-expression regions. Scale = 50 μm. (C)
Histograms comparing orienting and inductive activities of BMP/TGFβs in [d] explants, grouped according to orientation activity. Green bars
indicate angle of axonal orientation (mean± SEM): BMP9= 37.7 ± 1.6° (n = 31); BMP7= 35.0 ± 1.9° (n = 22); BMP4= 30.6 ± 1.2° (n = 14);
BMP2= 26.8 ± 1.6° (n = 20); GDF6= 18.8 ± 2.1° (n = 22); BMP5= 16.1 ± 1.8° (n = 28); dorsalin-1 = 11.8 ± 2.8° (n = 15); BMP6= 7.0 ± 2.2° (n = 24);
GDF5 = 6.6 ± 2.2° (n = 20); GDF7 = 3.7 ± 1.5° (n = 19); TGFβ3 =−2.1 ± 1.6° (n = 11); TGFβ2 = 0.56 ± 2.8° (n = 9); Activin A =−6.0 ± 1.2° (n = 21);
pMT23=−3.5 ± 1.6° (n = 14). Student’s t tests: Axon orientation responses to BMP5 and BMP6 were significantly different (P= 0.0022) with
responses to BMP7 significantly different from both BMP5 and BMP6 (P<0.0001), revealing three distinct levels of orienting activity in the BMP5/6/
7 subgroup. Red bars indicate Lhx2/9 induction (mean± SEM): BMP9= 203 ± 26% (n = 11); BMP7= 174 ± 33% (n = 6); BMP4= 175 ± 26% (n = 10);
BMP2= 158 ± 14% (n = 11); GDF6 = 173 ± 15% (n = 4); BMP5= 184 ± 31% (n = 7); dorsalin-1 = 205± 29% (n = 7); BMP6= 153 ± 18% (n = 7);
GDF5 = 198± 20% (n = 12); GDF7= 215 ± 18% (n = 14); TGFβ3 =−8 ± 6% (n = 10); TGFβ2 =−1 ± 4% (n = 9); Activin A =−5 ± 7% (n = 16). Inductive
activity is not statistically different among the BMPs (P= 0.5773, ANOVA). (D) Phylogenetic tree of BMPs and select other members of the TGFβ
superfamily. BMPs with robust orienting activity are highlighted in green. Dashed lines between (C) and (D) highlight differing orienting activities
yet close structural relationship of the BMP5/6/7 subgroup.
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tivity. Nonetheless, the functional distinctions remain
unresolved by this limited comparison.
To probe further the identity of residues that might con-
fer orienting activity, we next compared the sequences of
BMP6 and BMP7 with the sequences of the other BMPs
with robust orienting activity. Of the eight amino acid resi-
dues that are expressed in BMP6 but not BMP7, four arealso expressed in other robustly orienting BMPs (green
boxes in Figure 4B) and one (residue 36) contains a con-
servative substitution between BMP6 and BMPs2/9. Thus
these five residues seem unlikely to represent positions
critical for orienting activity. The three remaining diver-
gent residues, at positions 48, 65 and 98 in BMP6, are not
present in the corresponding positions in any of the BMPs
with orienting ability, including BMP5, designating these
Figure 4 Comparison of amino acid sequences of mature BMPs. Murine (m) sequences are aligned beginning two amino acids upstream
from the first conserved cysteine of the mature region [10] and numbered along the top according to BMP7 sequence. Numbering corresponding
to individual BMPs is shown to the left of each sequence. (A) Comparison of BMP6 with BMP7 and BMP5. Bold red letters in BMP6 and BMP7
indicate non-conservative amino acid differences. Orange letters in BMP5 indicate residues that are the same as those in BMP7. Green letters in
BMP5 represent residues the same as those found in BMP6. (B) Comparison of BMP6 with other BMPs that orient: BMP7, BMP2, BMP4 and BMP9.
Arrows indicate amino acid residues (36, 48, 65, 98 (BMP7 numbering)) that are unique in BMP6. Each of the other four amino acid differences in
BMP6 is shared by at least one other BMP with orienting activity (indicated by green boxes). At position 36, the residues in BMP2 and BMP9
(green boxes) represent a conservative substitution from that in BMP6.
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therefore next examined the influence of residues 48, 65
and 98 in BMP6 and BMP7 to confer or depress orienting
activity.
Residue swapping selectively alters BMP orienting ability
To test the functional importance of residues 48, 65 and
98 in BMP6 and BMP7, we generated single amino acid
substitutions individually in the BMP6 sequence to the
corresponding residues in BMP7 and examined the abil-
ity of BMP6/BMP7 chimeras to evoke growth cone col-
lapse, axon orientation and induction. Glutamine (Q) at
position 48 in BMP6 (Gln48) was substituted with argin-
ine (generating BMP6 Q48R), asparagine (N) at position
65 (Asn65) substituted with tyrosine (BMP6 N65Y) and
tyrosine at position 98 (Tyr98) substituted with threonine
(BMP6 Y98T). Unaltered (WT) and chimeric BMPs were
each HA tagged and expressed in COS-1 cells. Western
blot analysis of lysates, using α-HA antibodies, demon-
strated that all BMPs were expressed abundantly
(Figure 5A).
We first examined the abilities of BMP6/BMP7 chimeras
to evoke dI neuron growth cone collapse, comparing themwith the activities of BMP6 WT, BMP7 WT and rBMP7.
Dissociated dI neurons in sister cultures were incubated
with either COS-1 cell CM or rBMP7 and changes in
growth cone area were assessed as in Figure 1B, C. BMP7
WT CM caused reduction of growth cone area that was
not significantly different from that evoked by rBMP7
(41± 4.0% BMP7 WT; 37 ±0.2% rBMP7, compared to con-
trol CM from COS-1 cell cultures expressing vector alone;
Figure 5B). BMP6 WT CM did not cause significant
growth cone collapse (12± 2.3% reduction in growth cone
area; Figure 5B). Similarly, BMP6 N65Y and BMP6 Y98T
CM were ineffective in evoking growth cone collapse,
showing no improvement over BMP6 WT CM (13±4.9%
and 20± 3.1% reduction in growth cone area, respectively;
Figure 5B). In contrast, BMP6 Q48R CM caused a de-
crease in growth cone area (50± 4.4% reduction in growth
cone area; Figure 5B) that was similar to that stimulated
by BMP7 WT CM and rBMP7. The dramatic acquisition
of activity by BMP6 Q48R but not by BMP6 N65Y or
BMP6 Y98T suggested that residue 48 is important for the
ability of a BMP to evoke growth cone collapse.
We next tested the ability of BMP6 Q48R to orient dI
axons in [d] explants and the results strikingly mirrored
Figure 5 BMP6/BMP7 chimeras exhibit dramatically different growth cone collapse activity from that of BMP6 WT. (A) Western blot
analysis of whole cell lysates of COS-1 cells expressing control vector (pMT23) and HA-tagged native (WT) and chimeric BMP constructs. The
bands represent the 60 kDa BMP proprotein. The fully processed form is secreted into the COS-1 cell medium which is used as CM in growth
cone collapse assays. (B) Growth cone collapse activity of WT and chimeric BMPs. Percentage decrease of growth cone area relative to control
cultures (mean± SEM): rBMP7= 36.7 ± 0.3%; BMP7 WT= 40.7 ± 4.0%; BMP6 WT= 11.5 ± 2.3%; BMP6 N65Y= 13.3 ± 4.9%; BMP6 Y98T = 20.4 ± 3.1%;
BMP6 Q48R= 49.8 ± 4.5%; BMP6 Q48A= 46.8 ± 5.0%; BMP7 R48Q= 26.7 ± 5.7%. Student’s t tests: BMP6 Q48R- and BMP6 Q48A-evoked reduction of
growth cone area is significantly different from BMP6 WT treated cultures (***P= 0.0004 and ***P= 0.0007, respectively). BMP6 Q48R- and BMP6
Q48A-stimulated growth cone collapse is not different from BMP7 WT treated cultures (P= 0.2600 and P= 0.4425, respectively). Results are for 100
to 250 growth cones/condition/experiment; n = 2.
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WT did not orient dI axons (7.8±1.1°; Figure 6A, B), BMP6
Q48R oriented dI axons as effectively as BMP7 WT (BMP7
WT: 29±2.7°; BMP6 Q48R: 28±1.9°; Figure 6A, B). In con-
trast, the ability of BMP6 Q48R, and all other chimeras
tested, to induce Lhx2/9-expressing dI neurons in the same
[d] explants was unchanged in comparison to BMP6 WT
(Figure 6A, C and not shown). These results suggest that
residue 48 is a selective determinant of orienting ability.
Glutamine at position 48 depresses orienting activity
The ability of BMP6 Q48R to orient axons and evoke
growth cone collapse suggests either that there is a re-
quirement for Arg48 (which is large and positively charged)
or that Gln48 (which is large and uncharged) is inhibitory
to the selective BMP to BMPR interactions needed for
orientation activity. Inspection of the residues found in
other orienting BMPs, BMP2, BMP4 and BMP9, at the
position corresponding to Arg48 in BMP7 suggests that the
properties of Arg48 may not be explicitly required to con-
trol orientation activity: BMP2 and BMP4 show serine
(Ser) (which is small and uncharged) instead of arginineand BMP9 contains glutamic acid (Glu) (which is of
medium size and negatively charged) at this position
(Figure 4B). Nonetheless, Arg, Ser and Glu may each con-
fer orienting activity. To test this, we first asked whether
swapping Ser or Glu into position 48 in BMP6 would con-
fer orienting activity. Both BMP6 Q48S and BMP6 Q48E
showed strong orienting activity (33± 1.4° and 27±1.4°,
respectively; Figure 6A, B and not shown), appearing as
effective as BMP6 Q48R and BMP7 WT. As with BMP6
Q48R, both BMP6 Q48S and BMP6 Q48E showed similar
inductive activity to that of BMP6 WT (Figure 6A, C).
To determine whether the acquisition of orienting activity
by BMP6 Q48R, Q48S and Q48E chimeras reflects a re-
quirement specifically for any one of the three amino acids
found in other orienting BMPs, we replaced Gln48 in BMP6
with a generic amino acid, alanine (A). BMP6 Q48A evoked
robust growth cone collapse (47±5.0% reduction in growth
cone area; Figure 5B) and oriented dI axons within [d]
explants (40±2.4°; Figure 6B), showing similar responses to
those evoked by BMP6 Q48R. Together, these results sug-
gest that the beneficial effect of residue swapping into pos-
ition 48 may result from removal of Gln48 rather than a
Figure 6 BMP6 Gln48 residue appears to inhibit orienting activity without affecting dI induction. (A) Aggregates of COS-1 cells expressing
HA-tagged native (WT) and chimeric BMPs appended to [d] explants co-labeled with α-HA (blue), α-TAG-1 (green) and α-Lhx2/9 (red). Dashed
lines mark appended borders of aggregates and explants. Arrowheads indicate dI axons repelled by BMP6 Q48R, BMP6 Q48S and BMP7 WT.
Double arrowheads indicate reduced dI axon repulsion in explants exposed to BMP7 R48Q. Scale = 50 μm. (B) Angle of orientation in [d] explants
(mean ± SEM): BMP6 WT= 7.8 ± 1.1° (n = 11); BMP6 Q48R= 28.1 ± 1.9° (n = 22); BMP7 WT= 29.3 ± 2.7° (n = 11); BMP6 Q48S= 32.5 ± 1.4° (n = 4); BMP6
Q48E = 27.0 ± 2.1° (n = 3); BMP6 Q48A= 40.0 ± 2.4° (n = 8); BMP7 R48Q= 19.0 ± 2.9° (n = 16); pMT23=−4.8 ± 1.1° (n = 6). Student’s t tests: Axon
orientation evoked by each BMP6/BMP7 chimera is significantly different from that evoked by BMP6 WT (***P<0.0001). Axon orientation evoked
by BMP7 R48Q is significantly different from that evoked by BMP7 WT (*P<0.01). (C) Quantification of Lhx2/9 induction relative to control (pMT23)
exposed [d] explants (mean ± SEM): BMP6 WT= 228± 13% (n = 11); BMP6 Q48R= 252 ± 14% (n = 16); BMP7 WT= 289 ± 19% (n = 8); BMP6
Q48S = 241 ± 22% (n = 4); BMP6 Q48E = 290 ± 22% (n = 5); BMP7 R48Q= 274 ± 21% (n = 11). Inductive activity is not statistically different between
any of the native and chimeric BMPs (P= 0.1280, ANOVA).
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BMP6 to orient might be determined by Gln48 preventing
interaction between BMP6 and a BMPR at a critical inter-
face. To test the possibility that the Gln48 residue negatively
regulates activity in BMP6 we therefore generated a recipro-
cal BMP7 construct in which Arg48 in BMP7 was replaced
with Gln (BMP7 R48Q). Strikingly, BMP7 R48Q had sub-
stantially reduced growth cone collapse activity (27±5.7%
reduction in growth cone area; Figure 5B) and dI axon re-
pulsion (19±2.4°; Figure 6A, B) by comparison with BMP7
WTactivity, whereas inductive activity in the same explants
was unchanged (Figure 6A, C). These results suggest that
Gln48 determines the inability of BMP6 to orient axons.
Discussion
Here we have addressed an unexplained aspect of agonist
specificity in BMP signaling, a feature that may controlthe different functions of highly related BMPs during early
spinal cord development. We have explored the mechan-
ism by which two highly related BMPs have dramatically
different abilities to activate signaling that regulates cyto-
skeletal dynamics, leading to axon orientation, although
sharing the ability to evoke inductive signaling in the same
cell. That these distinct responses can be activated by a sin-
gle BMP and appear to depend on different receptor sub-
unit activation led us to examine the BMP family for
agonist properties that might influence selective BMP/
BMPR interactions. We show that the activities of the
whole family recapitulate the disparate functions of the
roof plate BMPs. Whereas all BMPs share the ability to in-
duce dI neuron differentiation, only a subset of the family
have axon orienting activity and this subset is not predicted
by overall sequence similarity. Exploiting the close similar-
ities of the BMP family, however, we identified amino acid
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BMPs. Generation of chimeric BMPs by single amino acid
substitutions has revealed a critical position at which the
residue confers or reduces orienting activity but does not
influence inductive activity. Although this critical residue is
unlikely to be the sole determinant of BMP orienting activ-
ity, it lies within the predicted interface between BMP7
and ActRIIA, a receptor required for orienting activity.
These results provide mechanistic insight into the ability of
BMPs to recruit distinct receptor complexes and elicit dif-
ferent functional outcomes.
Comparative analysis reveals residue 48 as critical for
orienting activity
Identification of BMPs as “orienting” or “non-orienting”
was fundamental to the structure/function analysis pre-
sented here and two lines of evidence provided confidence
that all BMPs were tested well within the functional con-
centration range for orientation. First, in Western blots of
COS-1 cell lysates and CM similar levels of efficient expres-
sion were observed for all native and chimeric constructs,
indicating that residue swapping did not interfere with
BMP processing or secretion. Second, in COS-1 cell CM,
BMPs were expressed in 25-fold excess of the concentra-
tion required for BMP7 to evoke orientation [9]. We and
others have shown that while neural induction and activa-
tion of associated downstream signaling components
requires high concentrations of BMPs, the orienting activ-
ities of BMP7, including growth cone collapse and mono-
cyte chemotaxis, occur at considerably lower
concentrations [3,4,9]. The finding that all 10 native BMPs
and each chimeric BMP induced the ectopic expression of
Lhx2/9 in [d] explants, and to a similar extent, suggests
that explants were exposed to comparable concentrations
of BMPs. Thus the observed absence of axon orienting
activity in BMP6 WTand BMP6 N65Y and Y98T chimeras,
as well as the reduction in axon orienting activity in the
BMP7 R48Q chimera, reflects an inability to activate the
relevant pathways through specific agonist properties and
leads to the conclusion that residue 48 in BMP6 and BMP7
influences receptor binding in a critical manner.
Residue 48 is unlikely to be the sole determinant of
orienting ability
Single amino acid substitutions in BMPs have previously
been shown to cause dramatic differences in BMP activities
and in BMPR binding [28-30]. The identification of the
residue at position 48 as critical for the orienting activity of
BMPs adds to this cannon. However, in experiments with
the reciprocal chimera, BMP7 R48Q, orienting activity is
reduced but not fully inhibited, indicating that residue 48
in BMP6/7 is not the only determinant of orienting activity,
and that there may be subtle mitigating effects from other
residues present in BMP7 but not BMP6. The existence ofadditional determinants is also suggested by our finding
that orienting activity across the BMP family is not simply
categorized in binary fashion. BMP5, most closely related
in sequence to BMP7 and BMP6, and containing an argin-
ine residue (Arg47) at the position corresponding to Arg48
in BMP7, typifies a group of BMPs with intermediate
orienting activity in [d] explants. In this functional study,
we chose first to examine residues in BMP6 and BMP7 that
were the most different from each other (non-conservative
amino acid substitutions). However, considering both con-
servative and non-conservative amino acid differences
observed in BMP6 and BMP7 sequences, several are
matched between the sequences of BMP5 and BMP6.
These residues are located mainly in a region thought to be
important for type I BMPR binding [23,26] and therefore
may not be involved directly in specific type II BMPR inter-
actions. Nonetheless, these and other differences present in
the BMP sequences may influence the conformation of the
BMP ligand and its interaction with the BMPR complex,
such that graduated functional outcomes are generated.
The intermediate orienting activity of BMP5 may therefore
be a useful tool, in conjunction with BMP6 and BMP7, with
which to identify amino acids that can confer BMP6-like or
BMP7-like activity upon BMP5 and to provide a more
comprehensive picture of the determinants for orienting
activity mediated by BMPs.How does residue 48 affect BMP agonist properties?
Crystal structure studies of BMP7 bound to ActRIIA show
that two of the BMP7 residues that differ in BMP6, Arg48
and Tyr65, lie within the predicted BMP7/ActRIIA inter-
face [22,23,26]. These two residues thus represent candi-
date regulators of selective interactions with ActRIIA, one
of the BMPR subunits that we have shown to be required
for orienting activity of BMP7 [8]. Replacing residue 65 in
BMP6 with Tyr, however, appeared not to confer orienting
activity on BMP6, but coordinate multiple residue swaps
might be necessary to reveal a more subtle role for residue
position 65. Notably, none of the BMP6 or BMP7 chimeras
altered BMP-evoked inductive signaling, revealing a singu-
lar role for residue 48 and representing a point of agonist/
receptor interaction required selectively for orientation.
However, our results throw into question the idea that spe-
cific amino acids are required to be present at position 48
in BMP7, BMP2/4 and BMP9 for orienting activity. Rather,
Arg, Ser and Glu may be permissive for this activity,
whereas the properties of Gln48 prevent BMP6 from acti-
vating the signaling apparatus that transduces orienting ac-
tivity. Indeed, the potencies of BMP6 Q48R, Q48S, Q48E
and Q48A in axon orientation were as high as that of
BMP9, the most potent of the BMPs, whereas in BMP7
swapping of Arg48 to Gln48 reduced orienting activity
dramatically.
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BMP7 lies within the ‘knuckle’ epitope, the major binding
interface of BMPs with type II BMPRs, but is not part of
the ‘wrist’ epitope, which is the main site in BMPs for type
I BMPR interaction [22,31]. Indeed, both Arg48 in BMP7
and Ser24 in BMP2/4 (equivalent positions) have been
implicated in high-affinity binding to type II BMPRs [22].
Furthermore, structural modeling predicts a direct inter-
action of Arg48 in BMP7 with Lys76 in ActRIIA (Figure 7D;
[30]). However, the residue at position 60 (BMP7 number-
ing) has also been implicated in type II BMPR binding
[23,30]. BMP7 and BMP6 differ at residue 60 (Figure 7C)
but this residue was eliminated from our functional ana-
lysis because BMP9 shares Lys60 with BMP6. Nevertheless,
the proximity of residues 48 and 60 raise the possibility
that together these residues prevent BMP6 from stimulat-
ing orienting activity. Indeed, comparison of the crystal
structures of BMP7 [32] and BMP6 [29,33] reveals signifi-
cant 3D differences in the region of the position 48 residue
(Figure 7A-C) and suggests that BMP7 has greater flexibil-
ity than BMP6 in the fingers that comprise the knuckle
epitope [30]. Although BMP6 and BMP7 have been shown
to have similar affinities for ActRIIA [29,33], the different
properties of the amino acids at position 48 in BMP6 (Gln,
large and uncharged) and BMP7 (Arg, large and charged)
as well as other BMPs that can orient (Ser, small and un-
charged; Glu, small and polar) (see Figure 7A-D), may
affect mode of binding rather than absolute binding
capacity.
Several studies have explored the importance of the
mode of binding of BMPs to receptor subunits. The cellu-
lar response to BMPs has been shown to depend on the
mode of receptor oligomerization [17,18,34]. BMP binding
to preformed receptor complexes drives Smad-dependent,
transcriptional pathways, whereas BMP-induced receptor
subunit assembly leads to non-transcriptional responses,
such as cytoskeletal rearrangements [17,18]. Although the
presence of the type I BMPR, BMPRIB, is necessary for
the orientation response [13], type I BMPR kinase activity,
which is required for BMP-evoked Smad phosphorylation
and inductive signaling, appears not to be important for
orientation [9]. In contrast, BMP7-evoked monocyte
chemotaxis requires the selective engagement of type II
BMPRs, ActRIIA and BMPRII [8]. Together, these data
suggest a model (Figure 7) in which BMP7 and other
orienting BMPs are able selectively to recruit a receptor
complex responsible for BMP orienting activity, pre-
sumably comprising ActRIIA, BMPRII and BMPRIB
(Figure 7E), whereas BMP6 is unable to stimulate orienting
activity through this receptor complex (Figure 7E), perhaps
prevented by structural differences in which the Gln48 resi-
due plays a key role in type II BMPR binding specificity. In
contrast, BMP-evoked inductive activity (Figure 7F), which
appears to be common to all BMPs but requires higheragonist concentrations and may reflect less stringent
requirements for BMPR binding, perhaps involving pre-
formed receptors.Conclusion
BMPs share the ability to induce the differentiation of dor-
sal spinal neurons, but only a subset exhibit orientation ac-
tivity toward the axons of these neurons. The closely
related BMP family members, BMP6 and BMP7 with 95%
similarity, most dramatically illustrate this difference.
BMP7 does and BMP6 does not display orienting activity.
We show here that a single amino acid residue at position
48 in BMP7 is a major determinant of BMP orienting activ-
ity. Residue swapping of Gln48 in BMP6 and Arg48 present
in BMP7 confers robust axon orienting ability upon BMP6
and reduces activity in BMP7. Moreover, replacing the
Gln48 residue in BMP6 with the corresponding residue in
other orienting BMPs permitted BMP6 to orient axons and
collapse growth cones of dI neurons. In contrast, none of
these manipulations altered BMP dI inductive activity. Our
results suggest that the presence of the Gln48 residue in
BMP6 is structurally inhibitory for transduction of the sig-
nals necessary for axon orientation by BMPs and provide a
basis for our mechanistic understanding of the diverse ac-
tivities of BMPs in spinal cord development.Materials and methods
Antibodies and reagents
Recombinant BMPs were purchased from R&D Systems,
Minneapolis, MN, USA, and stock solutions were prepared
in 4 mM HCl/0.1% BSA. Antibodies: mouse α-TAG-1
(4D7; [35]), rabbit α-Lhx2/9 (L1; [11]), mouse α-ERM (13
H9; [36]), rabbit α-HA, mouse α-HA (Abcam, Cambridge,
MA, USA), mouse α-myc (9E10; [37]), rabbit α-BMP9 (see
below). HRP- and fluorophore-conjugated secondary anti-
bodies were obtained from Jackson ImmunoResearch La-
boratories, West Grove, PA, USA. Cell culture reagents:
Ham’s F12 medium, Opti-MEM medium, Penicillin/
Streptomycin/Glutamine (P/S/G), Penicillin/Streptomycin
(P/S) (Invitrogen, Carlsbad, CA, USA), FBS (Gemini Bio-
Products, West Sacramento, CA, USA) and 45% glucose
(Sigma-Aldrich, St Louis, MO, USA). Pharmacological re-
agent: LY294002 (LY; Cell Signaling Technology, Danvers,
MA, USA): stock solution was prepared in DMSO and
subsequently diluted in serum-free Opti-MEM/P/S/G.
The α-BMP9 polyclonal antibody was generated by im-
munizing rabbits with a peptide (MGVPTLKYHYEG)
corresponding to C-terminal amino acids 133 through
144 in the mature coding sequence of mouse BMP9
(Covance Research Products, Inc., Denver, PA, USA).
The antiserum was affinity purified using the Montage
Antibody Purification Kit (Millipore Corporation, Bed-
ford, MA, USA).
Figure 7 Model of mechanism of BMP selectivity in axon orienting ability. (A-D) Ball and stick structural representations of BMP7, BMP6
and BMP7 bound to the AcRIIA ECD. The images were generated with Cn3D v4.3 software (http://www.ncbi.nlm.nih.gov), shown at low and
high magnification. (A) Views of the BMP7 monomer (PDB: 1LX1, [23] focusing on the region containing Arg48 (residue highlighted in yellow).
(B) Views of the BMP6 monomer (PDB: 2R52, [33]) in the proximity of Gln48 (yellow). (C) Enlargement and overlay of the boxed areas in the
lower panels in A and B illustrating the differences in the configuration of residues in this region: for BMP7, Arg48 and Glu60 (blue); for BMP6,
Gln48 (red) and Lys60 (brown). The arrangement of residues in this region is likely to influence binding specificity and subsequent functional
outcomes. (D) High magnification view of the BMP7/ActRIIA ECD complex (PDB: 1LX5; [23]. BMP7 is rotated with respect to the view in A to
illustrate the predicted interaction of Arg48 in BMP7 and Lys76 in ActRIIA. (E) Axon orientation and growth cone collapse is evoked by BMP7
but not by BMP6 and involves signaling dependent on PI3K [9] and, by analogy with BMP7-evoked monocyte chemotaxis [8], likely depends
on activation of ActRIIA. Our model proposes that BMP7 and other orienting BMPs are able selectively to activate a receptor complex
comprising ActRIIA, BMPRII and BMPRIB (see [8,9,13]) but that Gln48 in BMP6 prevents interaction with this complex. (F) The induction
pathway, activated by both BMP7 and BMP6, and all other BMPs, leads to stimulation of the Smad cascade and induction of target genes. This
transduction mechanism has a high threshold for activity, is not selectively dependent on any of the type II BMPRs [8,9] and is unaffected by
chimeric BMPs that alter orienting activity.
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Mouse cDNA was prepared from whole E11.5 embryos
with Superscript II reverse transcriptase (Invitrogen).
The mature regions of all BMP/TGFβ superfamily mem-
bers used in this study were generated by PCR using
gene-specific primers containing either myc (EQKLI-
SEEDL), flag (DYKDDDDK) or HA (YPYDVPDYA) epi-
tope tag insertions and cloned into pMT23 as previously
described [10,38].
BMP mutagenesis
Single amino acid mutations were performed using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA, USA). Primers were designed and used to
produce nucleotide changes in the native HA-tagged
mouse BMP6.pMT23 expression construct to yield the
Q48R, Q48A, Q48S, Q48E, N65Y and Y98T chimeras
and in the native HA-tagged mouse BMP7.pMT23 con-
struct to yield the R48Q chimera. The sequences were
verified by analysis (Genewiz, South Plainfield, NJ, USA).
Generation and characterization of conditioned medium
COS-1 cells plated in 35 mm dishes were transfected
with control vector (pMT23), epitope-tagged native or
chimeric BMP expression constructs by transfection with
either Lipofectamine Reagent or Lipofectamine LTX Re-
agent (Invitrogen). Following an overnight incubation,
the medium was replaced with 2 mL serum-free Opti-
MEM/P/S/G. Conditioned medium (CM) was collected
after 48 hours and used in growth cone collapse assays.
For analysis of secreted BMPs, CM was concentrated 20-
fold with Centricon YM-3 Amicon concentrators (Milli-
pore, Bedford, MA, USA). Concentrated CM or whole
cell lysates, prepared from transfected COS-1 cells using
1x Lysis Buffer (Cell Signaling Technology,) supplemen-
ted with 1 mM PMSF, were separated by SDS-PAGE
(EZ-Run Gel Solution, Fisher Scientific, Pittsburgh, PA,
USA) and transferred to nitrocellulose (Whatman, Clif-
ton, NJ, USA). Nitrocellulose membranes were blocked
in 5% non-fat milk/0.1% Tween 20/TBS (Blocking Buf-
fer) and probed overnight with epitope tag or BMP-
specific antibodies diluted in Blocking Buffer. Mem-
branes were washed in TBST (0.1% Tween 20/TBS) and
probed (1 hour) with HRP-conjugated secondary anti-
bodies in Blocking Buffer. After washing in TBST, blots
were developed using the Supersignal West Pico chemi-
luminescent substrate detection kit (Pierce, Rockford, IL,
USA) and exposed to Kodak BioMax Light Film Kodak,
Rochester, NY, USA).
Growth cone collapse assay
Dissociated dI neuron cultures were prepared as previ-
ously described [9]. The cultures were serum-starved byincubation in unsupplemented F12 medium for 2 hours
at 37°C and stimulated with rBMPs at 50 ng/ml or with
COS-1 cell CM (500μL) for 30 minutes. The cultures
were fixed in pre-warmed 4% paraformaldehyde/0.5%
gluteraldehyde/0.1 M phosphate buffer for 5 minutes,
washed once in PBS, blocked in 1% heat-inactivated goat
serum/0.1% Triton X-100/PBS and labeled with a mouse
α-ERM IgM and a Cy3 goat α-mouse IgM secondary
antibody. The growth cone area of neurons with axons
greater the 10 μm was measured across two or three
coverslips per condition for each experiment using Ima-
geJ 1.37v software (National Institutes of Health (NIH)).
Growth cone collapsing activity is presented as raw mean
area or as the percentage decrease of growth cone area
relative to control cultures.
[i] explant assays
Intermediate spinal cord ([i]) explants were dissected
from stage 10 chick embryos, cultured in collagen and
immunolabeled as previously described [39,40]. BMPs
(50 ng/ml) or 4 mM HCl/0.1% BSA (control) were incu-
bated with the explants for 48 hours.
[d] explant assays
E11 rat [d] explants were dissected, cultured and labeled
as previously described [4]. COS-1 cells were transfected
with epitope-tagged native or chimeric BMP expression
constructs using Lipofectamine Reagent or Lipofecta-
mine LTX Reagent (Invitrogen), aggregated [41] and
appended to [d] explants as described [4]. Explants were
immunolabeled with antibodies against TAG-1, Lhx2/9
and the epitope tag of the COS-1 cell-expressed BMP.
Lhx2/9 induction and the angle of reorientation of TAG-
1+ dI axons were measured in each explant in parallel.
Quantitation of Lhx2/9 induction, using ImageJ (NIH),
was performed by measuring the percentage change in
integrated density (mean pixel intensity x area) of the
BMP-induced region of Lhx2/9+ cells present in the ex-
plant relative to control (pMT23) explants. The angle of
reorientation was measured as shown previously [4].
Imaging
Images of dI neuron dissociated cultures were taken with a
Zeiss AxioCam HR digital camera (Carl Zeiss, Thornwood,
NY, USA) mounted on a Zeiss Axiovert 200 M fluores-
cence microscope. In addition, images of [i] and [d]
explants were taken using a Zeiss LSM 5 confocal micro-
scope and are presented here as confocal Z-stacks.
Alignments and dendrogram
Amino acid alignments of the mature regions of BMPs
were made using Vector NTI software (Invitrogen).
Sequences are aligned beginning two amino acids
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region [10,11]). The BMP/TGFβ phylogenetic tree den-
drogram was generated using ArboDraw v1.3 software
(http://dunbrack.fcccc.edu/ArboDraw). All sequences are
from mouse, except for chick dorsalin-1.
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